MIRA Pharmaceuticals (MIRA)

• Market cap: $55.7M
• 1 day: 4.72%
• 5 days: 11.76%
• 1 month: -0.75%
• 3 months: -9.52%
• 6 months: -4.32%
• Year to date: -10.74%
• 1 year: 29.13%
• 5 years: -82.08%
• 10 years: -82.08%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5